Litcius/Paper detail

Combination treatment of bortezomib and epirubicin increases the expression of TNFRSF10 A/B, and induces TRAIL-mediated cell death in colorectal cancer cells

Feyzanur Çaldıran, Çağlar Berkel, Esra Şafak Yılmaz, Burak Küçük, Aslihan Hatun Cacan, Şenol Çitli, Emel Canpolat, Ercan Çaçan, Ercan Çaçan

2023Biochemical and Biophysical Research Communications11 citationsDOI

Topics & Concepts

BortezomibProgrammed cell deathCancer researchColorectal cancerApoptosisDownregulation and upregulationReceptorMedicineCancerCD8Immune systemImmunologyBiologyInternal medicineMultiple myelomaGeneBiochemistryCell death mechanisms and regulationImmune cells in cancerCancer Immunotherapy and Biomarkers
Combination treatment of bortezomib and epirubicin increases the expression of TNFRSF10 A/B, and induces TRAIL-mediated cell death in colorectal cancer cells | Litcius